A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011)

NCT01254630 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

5305

Enrollment

INDUSTRY

Sponsor class

Conditions

Herpes Zoster

Interventions

BIOLOGICAL: V212
BIOLOGICAL: Placebo

Sponsor

Merck Sharp & Dohme LLC